Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Unimark Remedies Ltd.

Latest From Unimark Remedies Ltd.

Enforcement Log, Dateline 08.25.16: College Pharmacy, Frontida BioPharm, Unimark, Huzhou Aupower, Cape Apothecary, Hospira

Sterility assurance concerns and evidence of microbial contamination predominated in enforcement actions disclosed during the past week, including FDA warning letters, import alerts and EU GMP suspensions. But basic GMP failures were also an issue at some sites.

Manufacturing BioPharmaceutical

FTC's Generic Market Analysis Forcing Divestures Even In Diverse Categories

Hikma must divest rights to three drugs under Roxane Labs deal as Federal Trade Commission aims to preserve as many as five competitors in some markets.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Unimark Remedies Ltd.
  • Senior Management
  • Mehul Parekh, Mng. Dir.
    Om D Tyagi, COO
  • Contact Info
  • Unimark Remedies Ltd.
    Phone: 22 6730 4000
    Enterprise Center, Fl 1, Orchid Ln
    Nehru Rd, Vile
    Mumbai, 400099